Close

Notable 52-Week Highs and Lows 2/24: (HD) (APRI) (COT) High; (DAKT) (PDLI) (FUEL) Low

February 24, 2015 2:44 PM EST

52-Week High:
  • Home Depot (NYSE: HD) $117.92. Home Depot reported Q4 EPS of $1.00, $0.11 better than the analyst estimate of $0.89. Revenue for the quarter came in at $19.2 billion versus the consensus estimate of $18.7 billion. Comparable store sales for the fourth quarter of fiscal 2014 were positive 7.9 percent, and comp sales for U.S. stores were positive 8.9 percent. For more color, click here

  • Apricus Bioscience (Nasdaq: APRI) $2.71. In a 13D filing on Apricus Bioscience, hedge fund Sarissa Capital Management LP disclosed a 17.64%, or 9,271,757 share, stake in the company. This is up 800.17% from the 1,030,000 shares held at the end of the latest quarter ending December 31, 2014.

  • Cott Corp. (NYSE: COT) $8.91. Cott Corp. reported Q4 EPS of $0.37, which may not compare to the analyst estimate of ($0.01). Revenue for the quarter came in at $544 million versus the consensus estimate of $540.95 million.

  • DepoMed (Nasdaq:: DEPO) $22.83. DepoMed reported Q4 EPS of $0.21, $0.14 better than the analyst estimate of $0.07. Revenue for the quarter came in at $33.9 million versus $18.8 million last year. As of February 23, 2015, Depomed is providing its financial outlook for product revenue, excluding the effect from the NUCYNTA transaction, for the full year 2015:
52-Week Low:
  • Daktronics Inc. (Nasdaq: DAKT) $10.52. Daktronics reported Q3 revenue of $118.1 million and EPS of $0.01, from revenue of $115.4 million and EPS of $0.07 reported in the same period last year.

  • PDL BioPharma (Nasdaq: PDLI) $6.52. PDL BioPharma reported Q4 EPS of $0.32, $0.25 worse than the analyst estimate of $0.57. Revenue for the quarter came in at $117.1 million versus the consensus estimate of $158.15 million.

  • Rocket Fuel Inc. (Nasdaq: FUEL) $9.48. Rocket Fuel continuing lower from late last week after the company reported Q4 results, but issued light Q1 guidance. Shares fell over 35 percent the last three sessions.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Dividend, Hedge Funds, 13D